IO Biotech, Inc. (IOBTQ)

CIK 1865494 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for IO Biotech, Inc..

Recent SEC filings

FiledFormAccession number
Jun 8, 202625-NSE0001354457-26-000541
Jun 2, 2026SCHEDULE 13D/A0001591046-26-000008
May 20, 2026SCHEDULE 13G/A0000921895-26-001459
May 15, 2026SCHEDULE 13G/A0000919574-26-003515
Apr 6, 2026SCHEDULE 13G/A0001104659-26-039923
Mar 31, 20268-K0001193125-26-133331
Feb 13, 20268-K0001193125-26-051790
Feb 13, 2026SCHEDULE 13G/A0002042077-26-000015
Feb 6, 2026SCHEDULE 13G0000902664-26-000777
Jan 30, 20268-K0001193125-26-031987
Jan 23, 2026SCHEDULE 13D/A0001388325-26-000003
Jan 21, 20268-K0001193125-26-017164
Dec 19, 20258-K0001193125-25-327089
Nov 21, 20258-K0001193125-25-291504
Nov 18, 20258-K0001193125-25-285282
Nov 14, 20258-K0001193125-25-281657
Nov 14, 2025SCHEDULE 13G/A0001213900-25-111138
Nov 14, 202510-Q0001193125-25-281820
Nov 5, 2025SCHEDULE 13G0002042077-25-000006
Sep 29, 20258-K0001193125-25-221704
Aug 19, 2025SCHEDULE 13D/A0001415889-25-022324
Aug 14, 202510-Q0001193125-25-180860
Aug 14, 20258-K0001193125-25-180830
Aug 11, 20258-K0001193125-25-177471
Jul 31, 2025EFFECT9999999995-25-002438